Oncotelic Chief Business Officer Gives AI Drug Discovery Keynote at Drug Discovery Strategic Summit

• Oncotelic Therapeutics Chief Business Officer Saran Saund will deliver a keynote at the 22nd Drug Discovery Strategic Summit on October 22, 2026.
• The presentation runs from 9:00 to 9:25 a.m. Pacific Time at The Westin San Francisco Airport in Millbrae, California.
• Saund will discuss partition and aggregation in AI-enabled discovery, linking the approach to PDAOAI technology and planned genetic discovery expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200800PRIMZONEFULLFEED9849309) on October 20, 2026, and is solely responsible for the information contained therein.